Search research articles
Contact Us
Filters
Showing results (581-590 of 839) with videos related to
Page
of 84
Sort By:
Molecules (Basel, Switzerland)
|
October 16, 2024
Synthesis, Anti-Cancer Activity, Cell Cycle Arrest, Apoptosis Induction, and Docking Study of Fused Benzo[<i>h</i>]chromeno[2,3-<i>d</i>]pyrimidine on Human Breast Cancer Cell Line MCF-7
Zainab M Khoder, Mosaad S Mohamed, Samir M Awad, et al.
International Journal of Molecular Sciences
|
November 13, 2021
Synthesis of Novel 2-Thiouracil-5-Sulfonamide Derivatives as Potent Inducers of Cell Cycle Arrest and CDK2A Inhibition Supported by Molecular Docking
Samar S Fatahala, Amira I Sayed, Shahenda Mahgoub, et al.
Jac-Antimicrobial Resistance
|
March 2, 2022
Antimicrobial stewardship in companion animal practice: an implementation trial in 135 general practice veterinary clinics
L Y Hardefeldt, B Hur, S Richards, et al.
Frontiers in Oncology
|
June 24, 2022
Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study
Mark M Awad, Yvan Le Bruchec, Brian Lu, et al.
European Radiology
|
April 26, 2023
Advanced non-small-cell lung cancer treated with first-line pembrolizumab plus chemotherapy: tumor response dynamics as a marker for survival
Mizuki Nishino, Xinan Wang, Biagio Ricciuti, et al.
Journal for Immunotherapy of Cancer
|
October 6, 2020
Plasma IL-6 changes correlate to PD-1 inhibitor responses in NSCLC
Alissa Keegan, Biagio Ricciuti, Padric Garden, et al.
Cureus
|
August 22, 2025
Endocrine Disorders and COVID-19 Severity in Pediatric Populations: A Systematic Review
Afra Mohamed M Awad Abdu Alla, Hanady Me M Osman, Tayseer Ahmed Khalid Babikir, et al.
EJNMMI Research
|
November 2, 2021
Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer
Q Lecocq, P Debie, J Puttemans, et al.
International Journal of Cancer
|
March 7, 2020
Phase 1 study of epacadostat in combination with atezolizumab for patients with previously treated advanced nonsmall cell lung cancer
Matthew D Hellmann, Scott Gettinger, Laura Q M Chow, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2020
Clinicopathological and genomic correlates of programmed cell death ligand 1 (PD-L1) expression in nonsquamous non-small-cell lung cancer
G Lamberti, L F Spurr, Y Li, et al.
Page
of 84
Search research articles
Search
Showing results (581-590 of 839) with videos related to
Sort By:
Page
of 84
Molecules (Basel, Switzerland)
|
October 16, 2024
Synthesis, Anti-Cancer Activity, Cell Cycle Arrest, Apoptosis Induction, and Docking Study of Fused Benzo[<i>h</i>]chromeno[2,3-<i>d</i>]pyrimidine on Human Breast Cancer Cell Line MCF-7
Zainab M Khoder, Mosaad S Mohamed, Samir M Awad, et al.
International Journal of Molecular Sciences
|
November 13, 2021
Synthesis of Novel 2-Thiouracil-5-Sulfonamide Derivatives as Potent Inducers of Cell Cycle Arrest and CDK2A Inhibition Supported by Molecular Docking
Samar S Fatahala, Amira I Sayed, Shahenda Mahgoub, et al.
Jac-Antimicrobial Resistance
|
March 2, 2022
Antimicrobial stewardship in companion animal practice: an implementation trial in 135 general practice veterinary clinics
L Y Hardefeldt, B Hur, S Richards, et al.
Frontiers in Oncology
|
June 24, 2022
Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study
Mark M Awad, Yvan Le Bruchec, Brian Lu, et al.
European Radiology
|
April 26, 2023
Advanced non-small-cell lung cancer treated with first-line pembrolizumab plus chemotherapy: tumor response dynamics as a marker for survival
Mizuki Nishino, Xinan Wang, Biagio Ricciuti, et al.
Journal for Immunotherapy of Cancer
|
October 6, 2020
Plasma IL-6 changes correlate to PD-1 inhibitor responses in NSCLC
Alissa Keegan, Biagio Ricciuti, Padric Garden, et al.
Cureus
|
August 22, 2025
Endocrine Disorders and COVID-19 Severity in Pediatric Populations: A Systematic Review
Afra Mohamed M Awad Abdu Alla, Hanady Me M Osman, Tayseer Ahmed Khalid Babikir, et al.
EJNMMI Research
|
November 2, 2021
Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer
Q Lecocq, P Debie, J Puttemans, et al.
International Journal of Cancer
|
March 7, 2020
Phase 1 study of epacadostat in combination with atezolizumab for patients with previously treated advanced nonsmall cell lung cancer
Matthew D Hellmann, Scott Gettinger, Laura Q M Chow, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2020
Clinicopathological and genomic correlates of programmed cell death ligand 1 (PD-L1) expression in nonsquamous non-small-cell lung cancer
G Lamberti, L F Spurr, Y Li, et al.
Page
of 84